The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects.

[1]  D. Wong,et al.  The relationship between naloxone‐induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol‐dependent subjects , 2013, Addiction biology.

[2]  M. Galanter.  Recent Developments in Alcoholism , 2012, Springer US.

[3]  S. Ananthan,et al.  The delta opioid receptor antagonist, SoRI‐9409, decreases yohimbine stress‐induced reinstatement of ethanol‐seeking , 2012, Addiction biology.

[4]  Hiroto Kuwabara,et al.  Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. , 2011, Alcoholism, clinical and experimental research.

[5]  Hiroto Kuwabara,et al.  Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects , 2011, Psychoneuroendocrinology.

[6]  P. Robledo,et al.  Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid system , 2010, Neuroscience & Biobehavioral Reviews.

[7]  A. King,et al.  Acute HPA axis response to naltrexone differs in female vs. male smokers , 2010, Psychoneuroendocrinology.

[8]  B. Hoebel,et al.  Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. , 2010, Alcoholism, clinical and experimental research.

[9]  M. Leriche,et al.  Ethanol exposure selectively alters β-endorphin content but not [3H]-DAMGO binding in discrete regions of the rat brain , 2010, Neuropeptides.

[10]  Nicolette Marshall,et al.  Neural response to specific components of fearful faces in healthy and schizophrenic adults , 2010, NeuroImage.

[11]  B. Hoebel,et al.  Opioids in the nucleus accumbens stimulate ethanol intake , 2009, Physiology & Behavior.

[12]  A. Lê,et al.  Roles of opioid receptor subtypes in mediating alcohol‐seeking induced by discrete cues and context , 2009, The European journal of neuroscience.

[13]  J. Herman,et al.  Limbic Regulation of Hypothalamo‐Pituitary‐Adrenocortical Function during Acute and Chronic Stress , 2008, Annals of the New York Academy of Sciences.

[14]  R. Wise.  Dopamine and reward: The anhedonia hypothesis 30 years on , 2008, Neurotoxicity Research.

[15]  M. al’Absi,et al.  Blunted Opiate Modulation of Hypothalamic-Pituitary-Adrenocortical Activity in Men and Women Who Smoke , 2008, Psychosomatic medicine.

[16]  M. Morales-Mulia,et al.  Role of mu and delta opioid receptors in alcohol drinking behaviour. , 2008, Current drug abuse reviews.

[17]  Jae Sung Lee,et al.  Differences in δ- and μ-Opioid Receptor Blockade Measured by Positron Emission Tomography in Naltrexone-Treated Recently Abstinent Alcohol-Dependent Subjects , 2008, Neuropsychopharmacology.

[18]  D. Sarkar,et al.  Alcohol exposure during the developmental period induces beta-endorphin neuronal death and causes alteration in the opioid control of stress axis function. , 2007, Endocrinology.

[19]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  Lynn Oswald,et al.  Gender differences in hypothalamic–pituitary–adrenal (HPA) axis reactivity , 2006, Psychoneuroendocrinology.

[21]  Hiroshi Wachi,et al.  Chronic pain‐induced emotional dysfunction is associated with astrogliosis due to cortical δ‐opioid receptor dysfunction , 2006, Journal of neurochemistry.

[22]  N. Koshikawa,et al.  Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens , 2005, Neuroscience.

[23]  J. Zubieta,et al.  Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[24]  Morton B. Brown,et al.  Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 2: response to ovine corticotropin-releasing factor and naloxone. , 2005, Alcoholism, clinical and experimental research.

[25]  M. Gauthier,et al.  Brief exposure to predator odor and resultant anxiety enhances mesocorticolimbic activity and enkephalin expression in CD‐1 mice , 2004, The European journal of neuroscience.

[26]  G. Wand,et al.  GABRA6 gene polymorphism and an attenuated stress response , 2004, Molecular Psychiatry.

[27]  G. Wand,et al.  Opioids and alcoholism , 2004, Physiology & Behavior.

[28]  D. Sarkar,et al.  Chronic ethanol consumption impairs the circadian rhythm of pro‐opiomelanocortin and period genes mRNA expression in the hypothalamus of the male rat , 2004, Journal of neurochemistry.

[29]  M. Leriche,et al.  Acute ethanol administration transiently decreases [3H]-DAMGO binding to mu opioid receptors in the rat substantia nigra pars reticulata but not in the caudate-putamen , 2003, Neuroscience Research.

[30]  R. Irvine,et al.  Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for μ, δ, and κ opioid receptors in mouse brain homogenates , 2003, Brain Research.

[31]  Badreddine Bencherif,et al.  Quantification of brain mu-opioid receptors with [11C]carfentanil: reference-tissue methods. , 2003, Nuclear medicine and biology.

[32]  G. Wand,et al.  Naltrexone Dampens Ethanol-Induced Cardiovascular and Hypothalamic-Pituitary-Adrenal Axis Activation , 2001, Neuropsychopharmacology.

[33]  Jean-François Trottier,et al.  Role of endogenous opioid system in the regulation of the stress response , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[34]  I. Sora,et al.  Ethanol consumption and reward are decreased in µ-opiate receptor knockout mice , 2001, Psychopharmacology.

[35]  D. Dawson.  Drinking as a risk factor for sustained smoking. , 2000, Drug and alcohol dependence.

[36]  D. Wong,et al.  Column-switching HPLC for the analysis of plasma in PET imaging studies. , 2000, Nuclear medicine and biology.

[37]  M. McCaul,et al.  Naltrexone Alters Subjective and Psychomotor Responses to Alcohol in Heavy Drinking Subjects , 2000, Neuropsychopharmacology.

[38]  R. Sinha,et al.  Craving for alcohol: findings from the clinic and the laboratory. , 1999, Alcohol and alcoholism.

[39]  D. Hoover,et al.  Family history of alcoholism and hypothalamic opioidergic activity. , 1998, Archives of general psychiatry.

[40]  M. Kreek,et al.  Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. , 1998, Alcoholism, clinical and experimental research.

[41]  J. Franck,et al.  Modulation of Volitional Ethanol Intake in the Rat by Central δ‐Opioid Receptors , 1998 .

[42]  P. Micevych,et al.  Estrogen Modulation of Opioid and Cholecystokinin Systems in the Limbic-Hypothalamic Circuit , 1997, Brain Research Bulletin.

[43]  R. Lesser,et al.  Imaging of δ‐ and μ‐opioid receptors in temporal lobe epilepsy by positron emission tomography , 1997 .

[44]  H. Steiner,et al.  Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin , 1996, Nature.

[45]  Y. Hurd,et al.  Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain , 1996, Neuroscience.

[46]  P. Portoghese,et al.  The delta2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference , 1995, Pharmacology Biochemistry and Behavior.

[47]  S. Hyman,et al.  Proenkephalin gene regulation in the neuroendocrine hypothalamus: a model of gene regulation in the CNS. , 1995, The American journal of physiology.

[48]  C. Janssens,et al.  Chronic stress increases the opioid-mediated inhibition of the pituitary-adrenocortical response to acute stress in pigs. , 1995, Endocrinology.

[49]  W. Whelihan,et al.  Naltrexone-induced alterations in human ethanol intoxication. , 1994, The American journal of psychiatry.

[50]  J. Nurnberger,et al.  A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. , 1994, Journal of studies on alcohol.

[51]  S. Ceccatelli,et al.  Effect of different types of stressors on peptide messenger ribonucleic acids in the hypothalamic paraventricular nucleus. , 1993, Acta endocrinologica.

[52]  S. Lightman,et al.  Chronic stress elevates enkephalin expression in the rat paraventricular and supraoptic nuclei. , 1992, Brain research. Molecular brain research.

[53]  L. Lumeng,et al.  Importance of delta opioid receptors in maintaining high alcohol drinking , 1991, Psychopharmacology.

[54]  A. G. Watts.  Ether anesthesia differentially affects the content of prepro-corticotropin-releasing hormone, prepro-neurotensin/neuromedin N and prepro-enkephalin mRNAs in the hypothalamic paraventricular nucleus of the rat , 1991, Brain Research.

[55]  David J. Schlyer,et al.  Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[56]  Jonathan M. Links,et al.  Comparison of [11C]Diprenorphine and [11C]Carfentanil Binding to Opiate Receptors in Humans by Positron Emission Tomography , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[57]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[58]  J. Hunter,et al.  δ‐Opioid receptor binding sites in rodent spinal cord , 1990, British journal of pharmacology.

[59]  P. Portoghese,et al.  Design of peptidomimetic delta opioid receptor antagonists using the message-address concept. , 1990, Journal of medicinal chemistry.

[60]  C. Gianoulakis.  Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus. , 1990, European journal of pharmacology.

[61]  H. Holcomb,et al.  Anatomical localization for PET using MR imaging. , 1990, Journal of computer assisted tomography.

[62]  C. Naranjo,et al.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). , 1989, British journal of addiction.

[63]  M. Kuhar,et al.  μ Opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain , 1989 .

[64]  Paul Kinahan,et al.  Analytic 3D image reconstruction using all detected events , 1989 .

[65]  D. Pfaff,et al.  Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization , 1987, The Journal of comparative neurology.

[66]  J. Fallon,et al.  Distribution of dynorphin and enkephalin peptides in the rat brain , 1986, The Journal of comparative neurology.

[67]  A. Basbaum,et al.  Colocalization of immunoreactive proenkephalin and prodynorphin products in medullary neurons of the rat , 1984, Neuropeptides.

[68]  M. E. Lewis,et al.  Enkephalin systems in diencephalon and brainstem of the rat , 1983, The Journal of comparative neurology.

[69]  H. Akil,et al.  Comparison of the distribution of dynorphin systems and enkephalin systems in brain. , 1982, Science.

[70]  E. Sinforiani,et al.  Central Deficiency of β-Endorphin in Alcohol Addicts , 1982 .

[71]  H. Skinner,et al.  Alcohol dependence syndrome: measurement and validation. , 1982, Journal of abnormal psychology.

[72]  N. Rathod.  Society for the Study of Addiction , 1977 .

[73]  H. Edenberg,et al.  Pharmacogenetics of alcohol and alcohol dependence treatment. , 2010, Current pharmaceutical design.

[74]  G. Wand.  The Influence of Stress on the Transition From Drug Use to Addiction , 2008, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[75]  A. Heinz,et al.  Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. , 2005, Archives of general psychiatry.

[76]  R. Irvine,et al.  Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates. , 2003, Brain research.

[77]  S. O'Malley,et al.  Advances in the use of naltrexone: an integration of preclinical and clinical findings. , 2003, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.

[78]  G. Wand,et al.  The Mu-Opioid Receptor Gene Polymorphism (A118G) Alters HPA Axis Activation Induced by Opioid Receptor Blockade , 2002, Neuropsychopharmacology.

[79]  A. Dierich,et al.  Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. , 2000, Nature genetics.

[80]  G. Wand,et al.  Adrenocorticotropin responses to naloxone in sons of alcohol-dependent men. , 1999, The Journal of clinical endocrinology and metabolism.

[81]  J. Franck,et al.  Modulation of volitional ethanol intake in the rat by central delta-opioid receptors. , 1998, Alcoholism, clinical and experimental research.

[82]  R P Lesser,et al.  Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. , 1997, Annals of neurology.

[83]  G H Loew,et al.  Molecular determinants of mu receptor recognition for the fentanyl class of compounds. , 1992, Molecular pharmacology.

[84]  Linda C. Sobell,et al.  Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption , 1992 .

[85]  J. Székely.  Opioid peptides and stress. , 1990, Critical reviews in neurobiology.

[86]  Székely Ji.  Opioid peptides and stress. , 1990 .

[87]  M. Kuhar,et al.  Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain. , 1989, European journal of pharmacology.

[88]  K. Kangawa,et al.  High plasma concentrations of human atrial natriuretic polypeptide in aged men. , 1987, The Journal of clinical endocrinology and metabolism.